Ando A, Ando I, Katayama M, Sanada S, Hiraki T, Mori H, Tonami N, Hisada K
Eur J Nucl Med. 1987;12(11):567-72. doi: 10.1007/BF00296099.
The accumulation of 201Tl in tumor and inflammatory tissues were small. However, this nuclide showed a high concentration in viable tumor tissue, less in connective tissue (containing inflammatory tissue), and was not seen in necrotic tumor tissue regardless of the time after administration of 201Tl(I)-chloride. In inflammatory lesions, 201Tl accumulated in subcutaneous tissue infiltrated with neutrophils and macrophages, and quite large amounts of this nuclide were accumulated in subcutaneous tissue and sites where neutrophils were crowded. Most 201Tl existed in a free form in the fluid of tumor and inflammatory tissues regardless of the time after administration. A small amount of this nuclide was localized in the nuclear, mitochondrial and microsomal fractions in these tissues, and the nuclide was bound to protein in these fractions. The distribution of 201Tl(III)-chloride in tumor bearing animals was essentially the same as that of 201Tl(I)-chloride.
201铊在肿瘤组织和炎症组织中的蓄积量较少。然而,这种核素在存活的肿瘤组织中浓度较高,在结缔组织(包括炎症组织)中浓度较低,并且无论注射氯化201铊(I)后经过多长时间,在坏死的肿瘤组织中均未观察到。在炎症病变中,201铊蓄积于浸润有中性粒细胞和巨噬细胞的皮下组织,且在皮下组织和中性粒细胞聚集的部位蓄积了相当大量的这种核素。无论注射后经过多长时间,肿瘤组织和炎症组织液中的大部分201铊都以游离形式存在。在这些组织中,少量这种核素定位于细胞核、线粒体和微粒体部分,并且该核素与这些部分中的蛋白质结合。荷瘤动物体内氯化201铊(III)的分布与氯化201铊(I)基本相同。